|
DYM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44204656496549E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09898765035632E-12 |
| Normal-vs-Stage2 |
5.75299999999723E-05 |
| Normal-vs-Stage3 |
6.171400E-04 |
| Normal-vs-Stage4 |
1.483900E-02 |
| Stage1-vs-Stage2 |
5.255200E-01 |
| Stage1-vs-Stage3 |
3.875400E-01 |
| Stage1-vs-Stage4 |
7.754400E-01 |
| Stage2-vs-Stage3 |
9.001800E-01 |
| Stage2-vs-Stage4 |
8.640400E-01 |
| Stage3-vs-Stage4 |
8.161800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21378471110256E-12 |
| Normal-vs-AfricanAmerican |
6.28220000020718E-07 |
| Normal-vs-Asian |
8.02339999994572E-07 |
| Caucasian-vs-AfricanAmerican |
3.976600E-01 |
| Caucasian-vs-Asian |
4.405200E-01 |
| AfricanAmerican-vs-Asian |
3.274800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
1.431970E-02 |
| Male-vs-Female |
4.97690000000883E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.23069999999437E-05 |
| Normal-vs-Extreme_Weight |
1.62747593179802E-12 |
| Normal-vs-Obese |
4.32520000037684E-07 |
| Normal-vs-Extreme_Obese |
3.600100E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.142220E-01 |
| Normal_Weight-vs-Obese |
6.995400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.615000E-01 |
| Extreme_Weight-vs-Obese |
9.218700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.627600E-01 |
| Obese-vs-Extreme_Obese |
5.429400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.178900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.63620000776166E-09 |
| Normal-vs-Age(61-80Yrs) |
5.11812814352197E-14 |
| Normal-vs-Age(81-100Yrs) |
9.63439994450255E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.470800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.959580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.142420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.037500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.886400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.488600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
3.97999999957044E-07 |
| Normal-VS-KIRP CIMP |
8.432800E-01 |
| Normal-VS-Unclassified PRCC |
1.898270E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.074230E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.974040E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.226100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.875900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.076400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.206630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.12380019021441E-10 |
| Normal-vs-N1 |
5.302000E-03 |
| Normal-vs-N2 |
6.594000E-01 |
| N0-vs-N1 |
9.014400E-02 |
| N0-vs-N2 |
1.174190E-01 |
| N1-vs-N2 |
5.305000E-01 |
|
|
